Previous Section Index Home Page

23 Mar 2006 : Column 589W—continued

Purified Protein Derivative

Mr. Lansley: To ask the Secretary of State for Health pursuant to the answer of 6 February 2006, Official Report, column 993W, on purified protein derivative, when she expects data which would demonstrate the safety, quality and efficacy of the purified protein derivative used in Mantoux skin testing to be submitted to the Medicines and Healthcare products Regulatory Agency for its consideration; and what representations she has received on this matter. [57444]

Jane Kennedy: It would be for the applicant to consider when to submit an application for a marketing authorisation if sufficient data to demonstrate quality, safety and efficacy of the product are available.

There is currently no pending marketing authorisation application with the Medicines and Healthcare products Regulatory Agency for a purified protein derivative for Mantoux testing.

The Department has received representations on issues surrounding Mantoux and Ministers have dealt with a number of letters and parliamentary question 39325.

South-west London SHA

Mr. Davey: To ask the Secretary of State for Health whether the strategic health authority for South West London has been instructed that the health economy within its jurisdiction must balance its budget for 2005–06. [57120]

Jane Kennedy: All national health service organisations are expected to plan for and achieve financial balance.

Strategic health authorities (SHAs) are responsible for delivering overall financial balance for their local health economy. However, the month six, forecast for South West London SHA's overall economy at year-end suggests that financial balance is not going to be achieved this year.
23 Mar 2006 : Column 590W

At this late stage in the financial year, we would expect the SHA to take all reasonable actions to improve the financial position.

Telephone and Entertainment Systems

Mr. Pickles: To ask the Secretary of State for Health if she will list the NHS Trusts at which (a) Patientline and (b) other private service providers provide telephone and entertainment systems. [60200]

Jane Kennedy: The bedside entertainment systems are currently being provided by four service providers. They have an operational system in the national health service trusts listed as follows:

Hospital Telephone Services (HTS)


23 Mar 2006 : Column 591W

23 Mar 2006 : Column 592W

Premier Managed Payphones

Wandsworth Group

Mr. Pickles: To ask the Secretary of State for Health what guidance her Department has issued on the provision of premium telephone and entertainment systems to patients; and what advice about costs and alternatives patients are given. [60202]

Jane Kennedy: The Department has not issued guidance to patients on the provision of the bedside entertainment systems. These systems are run by private providers and offer additional services for the patient. Patients who wish to use the services are made aware of the charges at the time they sign up to use the system and by literature posted around the hospital.

Hospital payphones and televisions in day rooms are available for patients who do not wish to use the service.

Next Section Index Home Page